PDS Biotechnology (PDSB) Stock Highlights

1.65 | -5.71%

2024-12-21 06:44:23

PDS Biotechnology Corp operates as a clinical-stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Statistics

Range Today

1.63 1.81

Volume Today 578.7K

Range 1 Year

1.53 6.68

Volume 1 Year 150.25M

Range 3 Year

1.53 13.65

Volume 3 Year 435.11M

Range 10 Year

0.615 517.4

Volume 10 Year 954.7M

Highlights

Market Capitalization 121.14M (small)

Floating Shares 35.43M

Current Price 1.65

Price To Earnings -2.69

Price To Book 3.91

Earnings Per Share -1.23

Payout Ratio 0%

Performance

Latest -5.71%

1 Month -21.43%

3 Months -48.6%

6 Months -38.89%

1 Year -67.65%

3 Years -81.33%

5 Years -25%

10 Years -99.25%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.